Xylem Inc. (NYSE:XYL) Rating Reiterated by Canaccord Genuity

Canaccord Genuity restated their hold rating on shares of Xylem Inc. (NYSE:XYL) in a research report sent to investors on Wednesday, November 1st. They currently have a $65.00 price objective on the industrial products company’s stock.

A number of other equities analysts have also weighed in on the stock. Royal Bank Of Canada reiterated an outperform rating and issued a $71.00 price target (up from $64.00) on shares of Xylem in a research report on Wednesday, October 4th. Boenning Scattergood reiterated an outperform rating on shares of Xylem in a research report on Tuesday, September 5th. Stifel Nicolaus reiterated a hold rating and issued a $63.00 price target on shares of Xylem in a research report on Tuesday, September 5th. Zacks Investment Research raised shares of Xylem from a hold rating to a buy rating and set a $71.00 target price on the stock in a report on Thursday, October 5th. Finally, Oppenheimer Holdings, Inc. boosted their target price on shares of Xylem from $58.00 to $60.00 and gave the stock an outperform rating in a report on Wednesday, July 12th. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of Buy and a consensus price target of $65.17.

Shares of Xylem (NYSE:XYL) opened at $66.25 on Wednesday. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.88. The company has a market cap of $11,898.50, a P/E ratio of 28.93, a PEG ratio of 1.85 and a beta of 1.16. Xylem has a 12 month low of $46.67 and a 12 month high of $67.64.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.01. The company had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. Xylem had a net margin of 6.85% and a return on equity of 17.74%. The firm’s quarterly revenue was up 33.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.54 earnings per share. research analysts anticipate that Xylem will post 2.39 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Xylem Inc. (NYSE:XYL) Rating Reiterated by Canaccord Genuity” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/12/xylem-inc-xyl-rating-reiterated-by-canaccord-genuity.html.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Thursday, November 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Wednesday, November 1st. Xylem’s payout ratio is presently 41.86%.

In other Xylem news, Director Steven R. Loranger sold 37,700 shares of the stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the transaction, the director now directly owns 58,831 shares in the company, valued at approximately $3,897,553.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Colin R. Sabol sold 38,070 shares of the stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total transaction of $2,505,386.70. Following the sale, the insider now directly owns 61,979 shares of the company’s stock, valued at $4,078,837.99. The disclosure for this sale can be found here. 0.75% of the stock is owned by corporate insiders.

Institutional investors have recently made changes to their positions in the stock. Harfst & Associates Inc. raised its position in shares of Xylem by 26.1% in the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock valued at $134,000 after purchasing an additional 503 shares during the last quarter. CENTRAL TRUST Co raised its position in Xylem by 160.3% during the 2nd quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock worth $146,000 after buying an additional 1,635 shares during the last quarter. FNY Partners Fund LP raised its position in Xylem by 2,700.0% during the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after buying an additional 2,700 shares during the last quarter. Tower Research Capital LLC TRC acquired a new stake in shares of Xylem during the 2nd quarter worth approximately $168,000. Finally, Federated Investors Inc. PA grew its stake in shares of Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after purchasing an additional 181 shares during the period. 86.49% of the stock is owned by hedge funds and other institutional investors.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply